SEEL Seelos Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders.
On 3/14/2022 B. Riley Lower Price Target Buy rating for SEEl from $6.00 to $4.00.
52 Week Range 0.76 - 6.60
Is this a strong buy? Looking forward to read your opinion about it.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.